Skip to content

Unexpected shift in leadership at Carl Zeiss Meditec

Shocking leadership shift at Carl Zeiss Meditec: New CEO appointed

New Leadership Structure at Medical Tech Firm Carl Zeiss Meditec as Reflected in Recent Photos
New Leadership Structure at Medical Tech Firm Carl Zeiss Meditec as Reflected in Recent Photos

Maximilian Foerst Steps Up as New CEO at Carl Zeiss Meditec

Sudden Shift in Leadership at Carl Zeiss Meditec: New CEO Appointed - Unexpected shift in leadership at Carl Zeiss Meditec

Get ready for a shake-up at Carl Zeiss Meditec. Markus Weber, who's held the CEO position since early 2022, is calling it quits. Don't worry, though, as his departure comes in agreement with the board and is entirely at his own request. And fear not for the continuity of the company, as Maximilian Foerst - currently running the show in China - is taking the reins from Weber starting May 31.

Foerst has been with the company since 1995, working in product management, marketing, and sales for medical technology. He even led sales and service companies in France and Korea before taking charge of the Greater China region in 2009. This region accounts for a staggering 26% of the company's revenue, making it the most significant individual market. Despite previous struggles, Foerst managed to revitalize the company in the first quarter of 2023, which is impressive!

This move left investors feeling a bit uneasy, causing a 2.4% drop in shares.

  • CEO Succession
  • Medical Tech Firms
  • New Leadership
  • Jena
  • CEO Shuffle

Fun Fact: Maximilian Foerst's experience within ZEISS dates back over 25 years — talk about loyalty!

  1. Maximilian Foerst's long-standing tenure with ZEISS, spanning over 25 years, exemplifies a commitment to the company's community policy and employment policy.
  2. As the new CEO of Carl Zeiss Meditec, Maximilian Foerst brings a wealth of experience in medical technology, having worked in product management, marketing, and sales for ZEISS.
  3. Prior to his latest appointment, Maximilian Foerst led sales and service companies in France and Korea, showcasing his versatility in different business environments within the ZEISS employment policy.
  4. Maximilian Foerst's significant impact on the Greater China region, accounting for 26% of Carl Zeiss Meditec's revenue, provides an indication of his ability to drive growth and continuity within the finance and business sectors.
  5. The CEO shuffle at Carl Zeiss Meditec, with Markus Weber's departure and Maximilian Foerst's appointment, is a testament to the company's commitment to science, particularly in medical-conditions and health-and-wellness, as it continues to operate in Jena, Germany.

Read also:

    Latest